<!DOCTYPE html>
<html xmlns="http://www.w3.org/1999/xhtml" lang="en" xml:lang="en"><head>

<meta charset="utf-8">
<meta name="generator" content="quarto-1.3.340">

<meta name="viewport" content="width=device-width, initial-scale=1.0, user-scalable=yes">


<title>ust-gis-tumorleri-</title>
<style>
code{white-space: pre-wrap;}
span.smallcaps{font-variant: small-caps;}
div.columns{display: flex; gap: min(4vw, 1.5em);}
div.column{flex: auto; overflow-x: auto;}
div.hanging-indent{margin-left: 1.5em; text-indent: -1.5em;}
ul.task-list{list-style: none;}
ul.task-list li input[type="checkbox"] {
  width: 0.8em;
  margin: 0 0.8em 0.2em -1em; /* quarto-specific, see https://github.com/quarto-dev/quarto-cli/issues/4556 */ 
  vertical-align: middle;
}
</style>


<script src="ust-gis-tumorleri-_files/libs/clipboard/clipboard.min.js"></script>
<script src="ust-gis-tumorleri-_files/libs/quarto-html/quarto.js"></script>
<script src="ust-gis-tumorleri-_files/libs/quarto-html/popper.min.js"></script>
<script src="ust-gis-tumorleri-_files/libs/quarto-html/tippy.umd.min.js"></script>
<script src="ust-gis-tumorleri-_files/libs/quarto-html/anchor.min.js"></script>
<link href="ust-gis-tumorleri-_files/libs/quarto-html/tippy.css" rel="stylesheet">
<link href="ust-gis-tumorleri-_files/libs/quarto-html/quarto-syntax-highlighting.css" rel="stylesheet" id="quarto-text-highlighting-styles">
<script src="ust-gis-tumorleri-_files/libs/bootstrap/bootstrap.min.js"></script>
<link href="ust-gis-tumorleri-_files/libs/bootstrap/bootstrap-icons.css" rel="stylesheet">
<link href="ust-gis-tumorleri-_files/libs/bootstrap/bootstrap.min.css" rel="stylesheet" id="quarto-bootstrap" data-mode="light">


</head>

<body class="fullcontent">

<div id="quarto-content" class="page-columns page-rows-contents page-layout-article">

<main class="content" id="quarto-document-content">



<p><img src="img%5CU%CC%88st-GIS-Tu%CC%88mo%CC%88rleripptx-kopyas%C4%B10.jpg" class="img-fluid"></p>
<section id="üst-gis-tumorleri" class="level1">
<h1>Üst GIS Tümörleri</h1>
</section>
<section id="dr.-serdar-balci" class="level1">
<h1>Dr.&nbsp;Serdar BALCI</h1>
</section>
<section id="oral-kavite-tümörleri" class="level1">
<h1>ORAL KAVITE TÜMÖRLERI</h1>
</section>
<section id="skuamöz-hücreli-karsinom" class="level1">
<h1>Skuamöz Hücreli Karsinom</h1>
<ul>
<li><strong>Field cancerization (Saha kanserizayonu)</strong>
<ul>
<li><strong>Multipl primer tümör bağımsız olarak gelişir</strong></li>
<li><strong>Yıllar süren karsinojene maruziyet</strong></li>
</ul></li>
<li><strong>İki patogenez yolağı</strong>
<ul>
<li><strong>Kronik alkol ve tütün (içenler, çiğneyenler)</strong>
<ul>
<li><strong>TP53, p63 and NOTCH1</strong></li>
</ul></li>
<li><strong>HPV ilişkili</strong>
<ul>
<li><strong>Tonsillrr kript, dil kökü</strong></li>
<li><strong>HPV-16</strong></li>
<li><strong>Daha az mutasyon</strong></li>
<li><strong>p16 artmış ekspresyonu, siklin bağımlı kinaz inhibitörü</strong></li>
</ul></li>
</ul></li>
</ul>
<p><img src="img%5CU%CC%88st-GIS-Tu%CC%88mo%CC%88rleripptx-kopyas%C4%B11.png" class="img-fluid"></p>
<p><strong>Robbins and Cotran Pathologic Basis of Disease</strong></p>
<p><img src="img%5CU%CC%88st-GIS-Tu%CC%88mo%CC%88rleripptx-kopyas%C4%B12.png" class="img-fluid"></p>
<p><strong>Robbins and Cotran Pathologic Basis of Disease</strong></p>
</section>
<section id="tükrük-bezi-tümörleri" class="level1">
<h1>TÜKRÜK BEZI TÜMÖRLERI</h1>
<p><img src="img%5CU%CC%88st-GIS-Tu%CC%88mo%CC%88rleripptx-kopyas%C4%B13.png" class="img-fluid"></p>
<p><strong>Robbins and Cotran Pathologic Basis of Disease</strong></p>
<p><strong>Tümörler %65-80 parotis, %10 submandibüler bez, diğerleri sublingual ve minör tükrük bezlerinde</strong></p>
<p><strong>Malignite parotiste %15-30, %40 submandibular, %50 minor bezler, %70-90 sublingual</strong></p>
<p><em>Malignite gelişimi bez boyutu ile ters orantılı</em></p>
<p><img src="img%5CU%CC%88st-GIS-Tu%CC%88mo%CC%88rleripptx-kopyas%C4%B14.png" class="img-fluid"></p>
<p><strong>Pleomorphic adenoma</strong></p>
<p><strong>overexpress the transcription factor PLAG1</strong></p>
<p><strong>Robbins and Cotran Pathologic Basis of Disease</strong></p>
<p><img src="img%5CU%CC%88st-GIS-Tu%CC%88mo%CC%88rleripptx-kopyas%C4%B15.png" class="img-fluid"></p>
<p><strong>Pleomorphic adenoma</strong></p>
<p><strong>Robbins and Cotran Pathologic Basis of Disease</strong></p>
<p><img src="img%5CU%CC%88st-GIS-Tu%CC%88mo%CC%88rleripptx-kopyas%C4%B16.png" class="img-fluid"></p>
<p><strong>Robbins and Cotran Pathologic Basis of Disease</strong></p>
<p><img src="img%5CU%CC%88st-GIS-Tu%CC%88mo%CC%88rleripptx-kopyas%C4%B17.png" class="img-fluid"></p>
<p><strong>Robbins and Cotran Pathologic Basis of Disease</strong></p>
<p><img src="img%5CU%CC%88st-GIS-Tu%CC%88mo%CC%88rleripptx-kopyas%C4%B18.png" class="img-fluid"></p>
<p><strong>Mucoepidermoid carcinoma</strong></p>
<p><strong>chromosome rearrangements involving MAML2</strong></p>
<p><strong>signaling protein in the Notch pathway </strong></p>
<p><strong>Robbins and Cotran Pathologic Basis of Disease</strong></p>
<p><img src="img%5CU%CC%88st-GIS-Tu%CC%88mo%CC%88rleripptx-kopyas%C4%B19.png" class="img-fluid"></p>
<p><strong>Adenoid cystic carcinoma </strong></p>
<p><strong>Robbins and Cotran Pathologic Basis of Disease</strong></p>
<p><img src="img%5CU%CC%88st-GIS-Tu%CC%88mo%CC%88rleripptx-kopyas%C4%B110.png" class="img-fluid"></p>
<p><strong>Adenoid cystic carcinoma </strong></p>
<p><strong>Robbins and Cotran Pathologic Basis of Disease</strong></p>
</section>
<section id="odontojenik-kist-ve-tümörler" class="level1">
<h1>ODONTOJENIK KIST VE TÜMÖRLER</h1>
</section>
<section id="odontojenik-kist-ve-tümörler-1" class="level1">
<h1>Odontojenik Kist ve Tümörler</h1>
<p><strong>Çene kemiklerinde odontojenik kalıntılardan gelişen epitelyal kistler izlenir</strong></p>
<p><strong>Odontojenik keratokist lokal agresif, rekürrens gösterir</strong></p>
<p><strong>Periapikal kist düş çürükleri ve travmalar ile ilişkili</strong></p>
<p><strong>En sık görülen odontojenik tümörler ameloblastom ve odontom</strong></p>
<p><img src="img%5CU%CC%88st-GIS-Tu%CC%88mo%CC%88rleripptx-kopyas%C4%B111.png" class="img-fluid"></p>
<p><img src="img%5CU%CC%88st-GIS-Tu%CC%88mo%CC%88rleripptx-kopyas%C4%B112.png" class="img-fluid"></p>
</section>
<section id="özefagus-tümörleri" class="level1">
<h1>ÖZEFAGUS TÜMÖRLERI</h1>
</section>
<section id="özefagus-adenokarsinomu" class="level1">
<h1>Özefagus Adenokarsinomu</h1>
<p><strong>Barrett ve uzun süren GERH zemininde gelişir</strong></p>
<p><strong>Displazi varsa risk yüksek, sigara, obezite ve geçirilmiş radyoterapi riski artırır</strong></p>
<p><strong>Taze meyve ve sebzelerden zengin diyet riski azaltır</strong></p>
<ul>
<li><strong>Beyazlarda</strong></li>
<li><strong>Erkeklerde 7x daha fazla</strong></li>
<li><strong>En yüksek görülme gelişmiş batı ülkelerinde ABD, Britanya, Kanada, Avustralya, Hollanda,…</strong></li>
<li><strong>En düşük Kore, Tayland, Japonya, Ekvator</strong></li>
<li><strong>İnsidans 1970’lerden beri belirgin artoyor</strong>
<ul>
<li><strong>ABD’de özefagus tümörlerinin %5’inden yarısına yükseldi</strong></li>
</ul></li>
</ul>
<p><img src="img%5CU%CC%88st-GIS-Tu%CC%88mo%CC%88rleripptx-kopyas%C4%B113.png" class="img-fluid"></p>
<p><strong>N Engl J Med 2014;371:2499-509</strong></p>
<p><strong>Barrett özefagusunun adenokarsinoma ilerlemesi</strong></p>
<p><strong>Basmak şeklinde genetik ve epigenetik değişikliklerin birikmesi</strong></p>
<p><strong>TP53 mutasyonu tümörün erken edönemlerinde var</strong></p>
<p><img src="img%5CU%CC%88st-GIS-Tu%CC%88mo%CC%88rleripptx-kopyas%C4%B114.png" class="img-fluid"></p>
<ul>
<li><strong>Distal 1/3’te olur</strong></li>
<li><strong>Mide kardiasını invaze edebilir</strong></li>
<li><strong>Erken lezyonlar</strong>
<ul>
<li><strong>Düze ya da hafif kabarık</strong></li>
</ul></li>
<li><strong>İleri dönem</strong>
<ul>
<li><strong>Büyük egzofitik kitleler, diffüz infiltrasyon, derin infiltrasyon, ülser</strong></li>
</ul></li>
</ul>
<p><strong>Robbins Basic Pathology</strong></p>
<p><img src="img%5CU%CC%88st-GIS-Tu%CC%88mo%CC%88rleripptx-kopyas%C4%B115.png" class="img-fluid"></p>
<p><strong>Özefagus Adenokarsinomu</strong></p>
<p><strong>Barrett özefagusu tümör komşuluğunda görülebilir</strong></p>
<p><strong>Müsin üreten gland oluşumu izlenir</strong></p>
<p><strong>Robbins Basic Pathology</strong></p>
</section>
<section id="skuamöz-hücreli-karsinom-1" class="level1">
<h1>Skuamöz hücreli karsinom</h1>
<p><strong>&gt;45 yaş</strong></p>
<p><strong>Erkeklerde 4x daha fazla</strong></p>
<p><strong>Alkol ve tütün kullanımı, yakıcı özefagus hasarı, akalazya, Plummer-Vinson sendromu, çok sıcak içecek tüketimi, mediastene radyoterapi hikayesi</strong></p>
<p><strong>Zencilerde 6x daha fazla</strong></p>
<p><strong>En yüksek insidans Iran, merkezi Çin, Hong Kong, Arjantin, Brezilya, Güney Afrika</strong></p>
<p><strong>Alkol ve tütün kullanımı</strong></p>
<p><strong>Beslenme yetersizliği</strong></p>
<p><strong>Polikistik hidrokarbonlar, nitrözaminler, mantarla kontamine yiyecekler</strong></p>
<p><strong>HPV yüksek riskli bölgelerde var, düşük riskli bölgelerde yok</strong></p>
<p><strong>Yarısı özefagusun orta 1/3’ünde</strong></p>
<p><strong>Displazi, in situ olarak başlıyor</strong></p>
<p><strong>Erken lezyonlar küçük, gri-beyaz plak benzeri kalınlaşmalar şeklinde</strong></p>
<p><strong>Polipoid, lümene protrüde olup tıkanıklığa neden olurlar</strong></p>
<p><img src="img%5CU%CC%88st-GIS-Tu%CC%88mo%CC%88rleripptx-kopyas%C4%B116.png" class="img-fluid"></p>
<p><strong>En sık midözefagusta</strong></p>
<p><strong>Striktüre neden olur</strong></p>
<p><strong>Robbins Basic Pathology</strong></p>
<p><img src="img%5CU%CC%88st-GIS-Tu%CC%88mo%CC%88rleripptx-kopyas%C4%B117.png" class="img-fluid"></p>
<p><strong>Skuamöz hücreli karsinom</strong></p>
<p><strong>Çoğu orta- iyi diferansiye</strong></p>
<p><strong>Verrüköz, iğsi hücreli, bazaloid</strong></p>
<p><strong>Robbins Basic Pathology</strong></p>
<p><img src="img%5CU%CC%88st-GIS-Tu%CC%88mo%CC%88rleripptx-kopyas%C4%B118.png" class="img-fluid"></p>
</section>
<section id="yayılım" class="level1">
<h1>Yayılım</h1>
<p><strong>Submukozal lenfatik ağlar geniş</strong></p>
<p><strong>Çevresel ve dikey yayılım</strong></p>
<p><strong>İntramural tümör nodülleri</strong></p>
<p><strong>Üst 1/3 servikal LN</strong></p>
<p><strong>Orta 1/3 mediastinal, paratrakeal, trakeobronşial LN</strong></p>
<p><strong>Alt 1/3 gastrik ve çölyak LN</strong></p>
<p><strong>intramural tumor nodules</strong></p>
<p><strong>N Engl J Med 2014;371:2499-509</strong></p>
</section>
<section id="midenin-neoplastik-hastaliklari" class="level1">
<h1>MIDE’NIN NEOPLASTIK HASTALIKLARI</h1>
</section>
<section id="mide-polipleri" class="level1">
<h1>Mide polipleri</h1>
<p><strong>Üst GIS endoskopilerinin %5’inde</strong></p>
<p><strong>Epitel, stromal hücre hiperplazileri, inflamasyon, ektopi, neoplazi</strong></p>
</section>
<section id="inflamatuar-ve-hiperplastik-polipler" class="level1">
<h1>İnflamatuar ve hiperplastik polipler</h1>
<ul>
<li><strong>Tüm mide poliplerinin %75’i</strong></li>
<li><strong>50-60 yaş</strong></li>
<li><strong>Kronik gastrit zemininde</strong>
<ul>
<li><strong>Hasar ve reaktif hiperplazi polip büyümesine neden olur</strong></li>
<li><strong>H.pylori ile ilişkili ise, eradikasyon sonrası gerilerler</strong></li>
</ul></li>
</ul>
<p><img src="img%5CU%CC%88st-GIS-Tu%CC%88mo%CC%88rleripptx-kopyas%C4%B119.png" class="img-fluid"></p>
<p><img src="img%5CU%CC%88st-GIS-Tu%CC%88mo%CC%88rleripptx-kopyas%C4%B120.png" class="img-fluid"></p>
<p><strong>Multiple</strong></p>
<p><strong>Ovoid şekilli</strong></p>
<p><strong>&lt;1 cm</strong></p>
<p><strong>Yüzeyi düzgün</strong></p>
<p><img src="img%5CU%CC%88st-GIS-Tu%CC%88mo%CC%88rleripptx-kopyas%C4%B121.png" class="img-fluid"></p>
<p><strong>İrregüler, kistik genişlemiş, elonge foveolar bezler</strong></p>
<p><strong>Lamina propria ödemli, akut ve kronik inflamasyon</strong></p>
<p><strong>Displazi riski &gt;1.5 cm</strong></p>
<p><img src="img%5CU%CC%88st-GIS-Tu%CC%88mo%CC%88rleripptx-kopyas%C4%B122.png" class="img-fluid"></p>
<p><img src="img%5CU%CC%88st-GIS-Tu%CC%88mo%CC%88rleripptx-kopyas%C4%B123.png" class="img-fluid"></p>
<p><strong>İnflamatuar ve hiperplastik polipler</strong></p>
<p><strong>Robbins and Cotran Pathologic Basis of Disease</strong></p>
</section>
<section id="fundik-gland-polipleri" class="level1">
<h1>Fundik Gland Polipleri</h1>
<ul>
<li><strong>Sporadik</strong></li>
<li><strong>Familial adenomatous polyposis (FAP)</strong></li>
<li><strong>Kendilerinin neoplastik gelişimleri yok</strong></li>
<li><strong>İnsidansı artıyor</strong>
<ul>
<li><strong>Proton pompa inhibitörü kullanımı</strong></li>
</ul></li>
<li><strong>Azalmış asit → artmış gastrin → gland hiperplazisi</strong></li>
<li><strong>Asemptomatik, bulantı, kusma, epigastrik ağrı</strong></li>
<li><strong>İyi sınırlı polipler</strong></li>
<li><strong>Mide gövde, fundus</strong></li>
<li><strong>Multipl, kistik, dilate, irregüler bezler, parietal ve oksintik hücreler ile döşeli</strong></li>
</ul>
<p><img src="img%5CU%CC%88st-GIS-Tu%CC%88mo%CC%88rleripptx-kopyas%C4%B124.png" class="img-fluid"></p>
<p><strong>FLETCHER Diagnostic Histopathology of Tumors 4</strong> <strong>th</strong> __ Ed__</p>
<p><img src="img%5CU%CC%88st-GIS-Tu%CC%88mo%CC%88rleripptx-kopyas%C4%B125.png" class="img-fluid"></p>
<p><strong>Robbins and Cotran Pathologic Basis of Disease</strong></p>
<p><img src="img%5CU%CC%88st-GIS-Tu%CC%88mo%CC%88rleripptx-kopyas%C4%B126.png" class="img-fluid"></p>
</section>
<section id="gastrik-adenom" class="level1">
<h1>Gastrik Adenom</h1>
<p><strong>Mide poliplerinin %10’u</strong></p>
<p><strong>50-60 yaş</strong></p>
<p><strong>Erkeklerde 3x fazla</strong></p>
<p><strong>Adenokarsinoma riski &gt;2cm</strong></p>
<p><strong>Gastrik adenomların %30’unda karsinom bulunabilir</strong></p>
<p><strong>Robbins and Cotran Pathologic Basis of Disease</strong></p>
<p><img src="img%5CU%CC%88st-GIS-Tu%CC%88mo%CC%88rleripptx-kopyas%C4%B127.png" class="img-fluid"></p>
<ul>
<li><strong>En sık antrum</strong></li>
<li><strong>Intestinal tip kolumnar epitel</strong></li>
<li><strong>Tanım oalrak tüm GIS polipleri displazi içerir</strong>
<ul>
<li><strong>Düşük, yüksek dereceli</strong></li>
</ul></li>
</ul>
<p><strong>Robbins and Cotran Pathologic Basis of Disease</strong></p>
</section>
<section id="mide-adenokarsinomu" class="level1">
<h1>Mide adenokarsinomu</h1>
<ul>
<li><strong>Midenin en sık (&gt;%90) görülen malign tümörü</strong></li>
<li><strong>Japonya, Şili, Kosto Rika, Doğu avrupa’da 20x daha fazla</strong>
<ul>
<li><strong>Kuzey avrupa, afrika ve güneydoğu asyada daha az</strong></li>
</ul></li>
<li><strong>Japonya’da yeni tespit edilen vakaların %35’I mukoza ve submukozaya sınırlı</strong></li>
<li><strong>Genel olarak mide adenokarsinomu insidansında azalma var</strong>
<ul>
<li><strong>Mide kardia tümörleri ise artıyor</strong></li>
<li><strong>Barrett?, GERH?, obezite?</strong></li>
</ul></li>
</ul>
</section>
<section id="mide-kanserlerinin-patogenezi" class="level1">
<h1>Mide kanserlerinin patogenezi</h1>
<p><strong>Genetik olarak heterojen tümörler</strong></p>
<p><strong>Mutasyonlar</strong></p>
<p><strong>H.pylori</strong></p>
<p><strong>EBV</strong></p>
</section>
<section id="mide-kanserindeki-mutasyonlar" class="level1">
<h1>Mide kanserindeki mutasyonlar</h1>
<ul>
<li><strong>Çoğunluğu herediter değil</strong></li>
<li><strong>Ailesel mide kanserleri</strong>
<ul>
<li><strong>Diffüz</strong></li>
<li><strong>İntestinal</strong></li>
</ul></li>
</ul>
</section>
<section id="ailsel-mide-kanseri" class="level1">
<h1>Ailsel mide kanseri</h1>
<ul>
<li><strong>Diffüz tip</strong></li>
<li><strong>CDH1 germline mutasyon</strong>
<ul>
<li><strong>E-cadherin</strong></li>
</ul></li>
<li><strong>CDH1 mutasyonları</strong>
<ul>
<li><strong>Diffüz mide tümörlerinin %50’sinde</strong></li>
</ul></li>
<li><strong>E-cadherin</strong>
<ul>
<li><strong>Diğerlerinde ekspresyonda azalma var</strong></li>
<li><strong>CDH1 promotor metilasyonu</strong></li>
</ul></li>
</ul>
</section>
<section id="familial-adenomatous-polyposis" class="level1">
<h1>Familial adenomatous polyposis</h1>
<p><strong>APC geninde germline mutasyon</strong></p>
<p><strong>Intestinal tip mide kanseri riski artmış</strong></p>
</section>
<section id="sporadik-mide-kanseri" class="level1">
<h1>Sporadik mide kanseri</h1>
<ul>
<li><strong>Sporadik intestinal tip mide kanseri</strong>
<ul>
<li><strong>β-catenin kazanılmış mutasyonları</strong>
<ul>
<li><strong>E-cadherin ve APC ike ilişkili</strong></li>
</ul></li>
<li><strong>Mikrosatellit instabilitesi</strong></li>
<li><strong>Hipermetilasyon</strong>
<ul>
<li><strong>TGFβRII, BAX, IGFRII, p16/INK4a</strong></li>
</ul></li>
</ul></li>
<li><strong>Her iki tip sporadik mide kanserinde</strong>
<ul>
<li><strong>TP53 mutasyonları</strong></li>
</ul></li>
</ul>
</section>
<section id="h.-pylori" class="level1">
<h1>H. pylori</h1>
<ul>
<li><strong>Proinflamatuar proteinlerin üretimi</strong>
<ul>
<li><strong>interleukin-1β (IL-1β)</strong></li>
<li><strong>tumor necrosis factor (TNF)</strong></li>
</ul></li>
<li><strong>Sitokinlerin üretiminde polimorfizm</strong></li>
<li><strong>Kronik gastrit ilişkili H.pylori’nin eşlik ettiği intestinal tip adenokarsinom</strong></li>
</ul>
</section>
<section id="epstein-barr-virus" class="level1">
<h1>Epstein-Barr virus</h1>
<ul>
<li><strong>Mide adenokarsinomlarının %10’u</strong></li>
<li><strong>EBV epizomları tümörde klonal</strong>
<ul>
<li><strong>Infeksiyon neoplaziden önce olmuş</strong></li>
</ul></li>
<li><strong>TP53 mutasyonları sık değil</strong>
<ul>
<li><strong>Farklı bir moleküler altyapısı var</strong></li>
</ul></li>
<li><strong>Proksimal mide</strong></li>
<li><strong>Diffüz, belirgin lenfoid hücre içeren tümörler</strong></li>
</ul>
</section>
<section id="her2-amplifikasyonu" class="level1">
<h1>Her2 amplifikasyonu</h1>
<ul>
<li><strong>Günümüzde hedefe yönelik tedavide kullanılıyor</strong></li>
<li><strong>ToGA çalışması</strong></li>
<li><strong>İmmünohistokimya</strong>
<ul>
<li><strong>cerbB2</strong></li>
</ul></li>
<li><strong>In situ hibridizasyon</strong>
<ul>
<li><strong>CISH</strong></li>
<li><strong>FISH</strong></li>
</ul></li>
</ul>
</section>
<section id="lauren-sınıflaması" class="level1">
<h1>Lauren sınıflaması</h1>
<p><strong>İntestinal tip</strong></p>
<p><strong>Diffüz tip</strong></p>
<p><strong>büyük</strong></p>
<p><strong>Geniş birleşik sınırları</strong></p>
<p><strong>Egzofitik, ülsere tümör</strong></p>
<p><strong>Glandüler yapılar</strong></p>
<p><strong>Apikal müsin birikimi, gland içinde müsin birikimi</strong></p>
<ul>
<li><strong>Taşlı yüzük hücre</strong>
<ul>
<li><strong>Geniş sitoplazmik müsin birikimi</strong></li>
<li><strong>Perifere itilmiş, hilal şeklinde nükleus</strong></li>
</ul></li>
<li><strong>Infiltratif büyüme</strong></li>
<li><strong>Tek tek ya da küçük gruplar halinde infiltrasyon</strong></li>
<li><strong>Dezmoplastik reaksiyon</strong></li>
<li><strong>Matara mide</strong></li>
<li><strong>Linitis plastica</strong></li>
</ul>
<p><img src="img%5CU%CC%88st-GIS-Tu%CC%88mo%CC%88rleripptx-kopyas%C4%B128.png" class="img-fluid"></p>
<p><strong>Intestinal-type adenocarcinoma </strong></p>
<p><strong>Robbins Basic Pathology</strong></p>
<p><img src="img%5CU%CC%88st-GIS-Tu%CC%88mo%CC%88rleripptx-kopyas%C4%B129.png" class="img-fluid"></p>
<p><strong>Diffuse-type adenocarcinoma </strong></p>
<p><strong>Robbins Basic Pathology</strong></p>
<p><img src="img%5CU%CC%88st-GIS-Tu%CC%88mo%CC%88rleripptx-kopyas%C4%B130.png" class="img-fluid"></p>
<p><strong>Intestinal-type adenocarcinoma </strong></p>
<p><img src="img%5CU%CC%88st-GIS-Tu%CC%88mo%CC%88rleripptx-kopyas%C4%B131.png" class="img-fluid"></p>
<p><strong>Diffuse-type adenocarcinoma </strong></p>
<p><strong>Robbins Basic Pathology</strong></p>
</section>
<section id="mide-kanseri" class="level1">
<h1>Mide kanseri</h1>
<p><strong>İntestinal tip</strong></p>
<p><strong>Diffüz tip</strong></p>
<ul>
<li><strong>Yüksek riskli bölgelerde fazla</strong></li>
<li><strong>Öncül lezyonları</strong>
<ul>
<li><strong>Flat displazi ve adenom</strong></li>
</ul></li>
<li><strong>Ortalama yaş 55</strong></li>
<li><strong>E:K=2:1</strong></li>
<li><strong>İnsidansında azalma var</strong>
<ul>
<li><strong>Atrofik gastirt ve intestinal metaplazideki azalmaya bağlı?</strong></li>
</ul></li>
</ul>
<p><strong>İnsidans ülkeler arasında hemen hemen aynı</strong></p>
<p><strong>Belirgin prekürsör lezyon yok</strong></p>
<p><strong>Cinsiyetler arası fark yok</strong></p>
<ul>
<li><strong>TNM en önemli prognostik faktör</strong>
<ul>
<li><strong>İnvazyon derinliği</strong></li>
<li><strong>LN metastazı</strong></li>
<li><strong>Tanı anında uzak metastaz varlığı</strong></li>
</ul></li>
<li><strong>Duodenum, pankreas, retroperiton invazyonu karakteristik</strong></li>
<li><strong>Cerrahi önelikli tedavi seçeneği</strong></li>
<li><strong>Erken mide kanserlerinde (LN metastazı olsa bile) 5 yıllık sağkalım %90’larda</strong></li>
<li><strong>İleri evre tümörlerde 5 yıllık sağkalım %20’nin altında</strong></li>
</ul>
</section>
<section id="mide-lenfoması" class="level1">
<h1>Mide lenfoması</h1>
<ul>
<li><strong>Mide tümörlerinin %5’I primer mide lenfomaları</strong></li>
<li><strong>MALToma</strong>
<ul>
<li><strong>En sık</strong></li>
<li><strong>Indolan ekstranodal marjinal zon B hücreli lenfoma</strong></li>
<li><strong>lymphomas of mucosa-associated lymphoid tissue (MALT)</strong></li>
<li><strong>H.pylori</strong></li>
</ul></li>
<li><strong>Diffüz büyük B hücreli lenfoma</strong></li>
</ul>
<p><img src="img%5CU%CC%88st-GIS-Tu%CC%88mo%CC%88rleripptx-kopyas%C4%B132.png" class="img-fluid"></p>
<p><strong>Mide lenfoması</strong></p>
<p><strong>Lenfoepitelyal lezyon</strong></p>
<p><strong>Robbins and Cotran Pathologic Basis of Disease</strong></p>
</section>
<section id="nöroendokrin-tümörler" class="level1">
<h1>Nöroendokrin Tümörler</h1>
<ul>
<li><strong>Karsinoid tümörler</strong></li>
<li><strong>İlişkili olduğu durumlar;</strong>
<ul>
<li><strong>Endokrin hücre hiperplazisi</strong></li>
<li><strong>Kronik atrofik gastrit</strong></li>
<li><strong>Zollinger-Ellison syndrome</strong></li>
</ul></li>
<li><strong>Derece</strong>
<ul>
<li><strong>Mitoz</strong></li>
<li><strong>Ki-67 proliferasyon indeksi</strong></li>
</ul></li>
<li><strong>Prognostik olarak lokalizasyon, yayılım, atrofi ve intestinal metaplazi varlığı önemli</strong></li>
<li><strong>Yüksek dereceli nöroendokrin tümörler</strong>
<ul>
<li><strong>Nöroendokrin karsinom</strong></li>
</ul></li>
</ul>
<p><img src="img%5CU%CC%88st-GIS-Tu%CC%88mo%CC%88rleripptx-kopyas%C4%B133.png" class="img-fluid"></p>
<p><strong>Intramural veya submukozal kitleler</strong></p>
<p><strong>Küçük polipoid lezyonlar</strong></p>
<p><strong>Sarı beyaz renkli</strong></p>
<p><strong>Yoğun dezmoplastik reaksiyona neden olurlar,</strong></p>
<p><strong>Barsak duvarında katlanma ve obstrüksiyona neden olur</strong></p>
<p><strong>Robbins Basic Pathology</strong></p>
<p><img src="img%5CU%CC%88st-GIS-Tu%CC%88mo%CC%88rleripptx-kopyas%C4%B134.png" class="img-fluid"></p>
<p><strong>Nöroendokrin Tümörler</strong></p>
<p><strong>Adalar, trabeküller, diziler, gland ve tabaka halinde uniform hücreler</strong></p>
<p><strong>Belli belirsiz, pembe granüler sitoplazma</strong></p>
<p><strong>Yuvarlak, oval nükleus</strong></p>
<p><strong>Tuz biber kromatin</strong></p>
<p><strong>Robbins Basic Pathology</strong></p>
</section>
<section id="location-of-neuroendocrine-tumors" class="level1">
<h1>Location of neuroendocrine tumors</h1>
<ul>
<li><strong>Foregut</strong>
<ul>
<li><strong>stomach, duodenum proximal to the ligament of Treitz, and esophagus</strong></li>
<li><strong>rarely metastasize</strong></li>
<li><strong>cured by resection</strong></li>
<li><strong>Duodenal gastrin-producing carcinoid tumors, gastrinomas, have been associated with proton pump inhibitor therapy</strong></li>
</ul></li>
<li><strong>Midgut</strong>
<ul>
<li><strong>jejunum and ileum</strong></li>
<li><strong>often multiple</strong></li>
<li><strong>tend to be aggressive</strong></li>
<li><strong>greater depth of local invasion, increased size, and presence of necrosis and mitosis are associated with poor outcome</strong></li>
</ul></li>
<li><strong>Hindgut</strong>
<ul>
<li><strong>appendix and colorectum</strong></li>
<li><strong>discovered incidentally</strong></li>
<li><strong>appendix NETs occur at any age and are almost uniformly benign</strong></li>
<li><strong>Rectal carcinoid tumors tend to produce polypeptide hormones and may manifest with abdominal pain and weight loss; they only occasionally metastasize</strong></li>
</ul></li>
</ul>
</section>
<section id="mezenkimal-neoplazmlar" class="level1">
<h1>Mezenkimal Neoplazmlar</h1>
<p><strong>Leiomyom, leiomyosarkom</strong></p>
<p><strong>Schwannom</strong></p>
<p><strong>Glomus tümör</strong></p>
<p><strong>Gastrointestinal Stromal Tumor</strong></p>
</section>
<section id="gastrointestinal-stromal-tumor" class="level1">
<h1>Gastrointestinal Stromal Tumor</h1>
<ul>
<li><strong>Erkeklerde biraz daha fazla</strong></li>
<li><strong>60 yaş</strong></li>
<li><strong>&lt;10%, &lt;40 yaş altında</strong></li>
<li><strong>interstitial cells of Cajal </strong>
<ul>
<li><strong>c-KIT eksprese eden</strong></li>
<li><strong>Muskularis propria yerleşimli</strong></li>
<li><strong>GIS peristalsizmi için pacemaker oalrak çalışan</strong></li>
</ul></li>
<li><strong>c-KIT mutasyonu</strong>
<ul>
<li><strong>%75-80</strong></li>
<li><strong>Aktive edici mutasyon</strong></li>
<li><strong>Tirozin kinaz</strong></li>
<li><strong>Kök hücre faktörü için reseptör</strong></li>
</ul></li>
<li><strong>PDGFRA</strong>
<ul>
<li><strong>%8</strong></li>
<li><strong>Ilişkili diğer tirozin kinaz platelet-derived growth factor receptor A</strong></li>
</ul></li>
<li><strong>Herhangi bir mutasyon tümör gelişimi için yeterli, birarada hiç yoklar</strong></li>
</ul>
<p><img src="img%5CU%CC%88st-GIS-Tu%CC%88mo%CC%88rleripptx-kopyas%C4%B135.png" class="img-fluid"></p>
</section>
<section id="gist" class="level1">
<h1>GIST</h1>
<ul>
<li><strong>soliter</strong></li>
<li><strong>Iyi sınırlı</strong></li>
<li><strong>Etsi</strong></li>
<li><strong>Submukozal kitle</strong></li>
<li><strong>Boyut (5cm, 10cm sınırları), mitoz prognoz açısından önemli</strong></li>
<li><strong>Hedefe yönelik tedavi</strong>
<ul>
<li><strong>imatinib</strong></li>
</ul></li>
</ul>
<p><strong>Robbins and Cotran Pathologic Basis of Disease</strong></p>
<p><img src="img%5CU%CC%88st-GIS-Tu%CC%88mo%CC%88rleripptx-kopyas%C4%B136.png" class="img-fluid"></p>
<p><strong>Autopsy Pathology: A Manual and Atlas</strong></p>
<p><img src="img%5CU%CC%88st-GIS-Tu%CC%88mo%CC%88rleripptx-kopyas%C4%B137.png" class="img-fluid"></p>
<p><strong>Autopsy Pathology: A Manual and Atlas</strong></p>
<p><img src="img%5CU%CC%88st-GIS-Tu%CC%88mo%CC%88rleripptx-kopyas%C4%B138.png" class="img-fluid"></p>
<p><strong>Autopsy Pathology: A Manual and Atlas</strong></p>
<p><img src="img%5CU%CC%88st-GIS-Tu%CC%88mo%CC%88rleripptx-kopyas%C4%B139.png" class="img-fluid"></p>
<p><strong>Autopsy Pathology: A Manual and Atlas</strong></p>
</section>

</main>
<!-- /main column -->
<script id="quarto-html-after-body" type="application/javascript">
window.document.addEventListener("DOMContentLoaded", function (event) {
  const toggleBodyColorMode = (bsSheetEl) => {
    const mode = bsSheetEl.getAttribute("data-mode");
    const bodyEl = window.document.querySelector("body");
    if (mode === "dark") {
      bodyEl.classList.add("quarto-dark");
      bodyEl.classList.remove("quarto-light");
    } else {
      bodyEl.classList.add("quarto-light");
      bodyEl.classList.remove("quarto-dark");
    }
  }
  const toggleBodyColorPrimary = () => {
    const bsSheetEl = window.document.querySelector("link#quarto-bootstrap");
    if (bsSheetEl) {
      toggleBodyColorMode(bsSheetEl);
    }
  }
  toggleBodyColorPrimary();  
  const icon = "";
  const anchorJS = new window.AnchorJS();
  anchorJS.options = {
    placement: 'right',
    icon: icon
  };
  anchorJS.add('.anchored');
  const isCodeAnnotation = (el) => {
    for (const clz of el.classList) {
      if (clz.startsWith('code-annotation-')) {                     
        return true;
      }
    }
    return false;
  }
  const clipboard = new window.ClipboardJS('.code-copy-button', {
    text: function(trigger) {
      const codeEl = trigger.previousElementSibling.cloneNode(true);
      for (const childEl of codeEl.children) {
        if (isCodeAnnotation(childEl)) {
          childEl.remove();
        }
      }
      return codeEl.innerText;
    }
  });
  clipboard.on('success', function(e) {
    // button target
    const button = e.trigger;
    // don't keep focus
    button.blur();
    // flash "checked"
    button.classList.add('code-copy-button-checked');
    var currentTitle = button.getAttribute("title");
    button.setAttribute("title", "Copied!");
    let tooltip;
    if (window.bootstrap) {
      button.setAttribute("data-bs-toggle", "tooltip");
      button.setAttribute("data-bs-placement", "left");
      button.setAttribute("data-bs-title", "Copied!");
      tooltip = new bootstrap.Tooltip(button, 
        { trigger: "manual", 
          customClass: "code-copy-button-tooltip",
          offset: [0, -8]});
      tooltip.show();    
    }
    setTimeout(function() {
      if (tooltip) {
        tooltip.hide();
        button.removeAttribute("data-bs-title");
        button.removeAttribute("data-bs-toggle");
        button.removeAttribute("data-bs-placement");
      }
      button.setAttribute("title", currentTitle);
      button.classList.remove('code-copy-button-checked');
    }, 1000);
    // clear code selection
    e.clearSelection();
  });
  function tippyHover(el, contentFn) {
    const config = {
      allowHTML: true,
      content: contentFn,
      maxWidth: 500,
      delay: 100,
      arrow: false,
      appendTo: function(el) {
          return el.parentElement;
      },
      interactive: true,
      interactiveBorder: 10,
      theme: 'quarto',
      placement: 'bottom-start'
    };
    window.tippy(el, config); 
  }
  const noterefs = window.document.querySelectorAll('a[role="doc-noteref"]');
  for (var i=0; i<noterefs.length; i++) {
    const ref = noterefs[i];
    tippyHover(ref, function() {
      // use id or data attribute instead here
      let href = ref.getAttribute('data-footnote-href') || ref.getAttribute('href');
      try { href = new URL(href).hash; } catch {}
      const id = href.replace(/^#\/?/, "");
      const note = window.document.getElementById(id);
      return note.innerHTML;
    });
  }
      let selectedAnnoteEl;
      const selectorForAnnotation = ( cell, annotation) => {
        let cellAttr = 'data-code-cell="' + cell + '"';
        let lineAttr = 'data-code-annotation="' +  annotation + '"';
        const selector = 'span[' + cellAttr + '][' + lineAttr + ']';
        return selector;
      }
      const selectCodeLines = (annoteEl) => {
        const doc = window.document;
        const targetCell = annoteEl.getAttribute("data-target-cell");
        const targetAnnotation = annoteEl.getAttribute("data-target-annotation");
        const annoteSpan = window.document.querySelector(selectorForAnnotation(targetCell, targetAnnotation));
        const lines = annoteSpan.getAttribute("data-code-lines").split(",");
        const lineIds = lines.map((line) => {
          return targetCell + "-" + line;
        })
        let top = null;
        let height = null;
        let parent = null;
        if (lineIds.length > 0) {
            //compute the position of the single el (top and bottom and make a div)
            const el = window.document.getElementById(lineIds[0]);
            top = el.offsetTop;
            height = el.offsetHeight;
            parent = el.parentElement.parentElement;
          if (lineIds.length > 1) {
            const lastEl = window.document.getElementById(lineIds[lineIds.length - 1]);
            const bottom = lastEl.offsetTop + lastEl.offsetHeight;
            height = bottom - top;
          }
          if (top !== null && height !== null && parent !== null) {
            // cook up a div (if necessary) and position it 
            let div = window.document.getElementById("code-annotation-line-highlight");
            if (div === null) {
              div = window.document.createElement("div");
              div.setAttribute("id", "code-annotation-line-highlight");
              div.style.position = 'absolute';
              parent.appendChild(div);
            }
            div.style.top = top - 2 + "px";
            div.style.height = height + 4 + "px";
            let gutterDiv = window.document.getElementById("code-annotation-line-highlight-gutter");
            if (gutterDiv === null) {
              gutterDiv = window.document.createElement("div");
              gutterDiv.setAttribute("id", "code-annotation-line-highlight-gutter");
              gutterDiv.style.position = 'absolute';
              const codeCell = window.document.getElementById(targetCell);
              const gutter = codeCell.querySelector('.code-annotation-gutter');
              gutter.appendChild(gutterDiv);
            }
            gutterDiv.style.top = top - 2 + "px";
            gutterDiv.style.height = height + 4 + "px";
          }
          selectedAnnoteEl = annoteEl;
        }
      };
      const unselectCodeLines = () => {
        const elementsIds = ["code-annotation-line-highlight", "code-annotation-line-highlight-gutter"];
        elementsIds.forEach((elId) => {
          const div = window.document.getElementById(elId);
          if (div) {
            div.remove();
          }
        });
        selectedAnnoteEl = undefined;
      };
      // Attach click handler to the DT
      const annoteDls = window.document.querySelectorAll('dt[data-target-cell]');
      for (const annoteDlNode of annoteDls) {
        annoteDlNode.addEventListener('click', (event) => {
          const clickedEl = event.target;
          if (clickedEl !== selectedAnnoteEl) {
            unselectCodeLines();
            const activeEl = window.document.querySelector('dt[data-target-cell].code-annotation-active');
            if (activeEl) {
              activeEl.classList.remove('code-annotation-active');
            }
            selectCodeLines(clickedEl);
            clickedEl.classList.add('code-annotation-active');
          } else {
            // Unselect the line
            unselectCodeLines();
            clickedEl.classList.remove('code-annotation-active');
          }
        });
      }
  const findCites = (el) => {
    const parentEl = el.parentElement;
    if (parentEl) {
      const cites = parentEl.dataset.cites;
      if (cites) {
        return {
          el,
          cites: cites.split(' ')
        };
      } else {
        return findCites(el.parentElement)
      }
    } else {
      return undefined;
    }
  };
  var bibliorefs = window.document.querySelectorAll('a[role="doc-biblioref"]');
  for (var i=0; i<bibliorefs.length; i++) {
    const ref = bibliorefs[i];
    const citeInfo = findCites(ref);
    if (citeInfo) {
      tippyHover(citeInfo.el, function() {
        var popup = window.document.createElement('div');
        citeInfo.cites.forEach(function(cite) {
          var citeDiv = window.document.createElement('div');
          citeDiv.classList.add('hanging-indent');
          citeDiv.classList.add('csl-entry');
          var biblioDiv = window.document.getElementById('ref-' + cite);
          if (biblioDiv) {
            citeDiv.innerHTML = biblioDiv.innerHTML;
          }
          popup.appendChild(citeDiv);
        });
        return popup.innerHTML;
      });
    }
  }
});
</script>
</div> <!-- /content -->



</body></html>